BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...

The US drug regulator has missed a deadline for granting full approval to Novavax's Covid-19 vaccine, the company said on ...

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

It comes on the heels of the FDA's top vaccine scientist Peter Marks' exit from the agency, which will be effective April 5.

The FDA delays full approval for Novavax's COVID-19 vaccine, citing the need for additional data. Read more here.